News

Consult Lhasa is delighted to announce the acquisition of Spektra Consultoria.
The acquisition builds upon years of successful collaboration between Consult Lhasa, Lhasa Limited, and Spektra.

New Consult Lhasa Health-Based Exposure Limits (HBELs) service helps to manage cross-contamination in pharmaceutical manufacturing, defining threshold values for safer medicines.

Consult Lhasa, a wholly owned subsidiary of Lhasa Limited, has been launched to provide expert scientific risk assessments to the pharmaceutical industry. This launch marks a significant milestone in Lhasa Limited commitment to enabling informed decision-making on chemical safety.